A Case of Sitagliptin Induced DRESS Syndrome
- Author:
Jae-Ho LEE
1
;
Joong-Ho KIM
;
Ho-Young KIM
;
Joong-Heon SUH
;
Soo-Kyung LEE
;
Myoung-Shin KIM
;
Un-Ha LEE
Author Information
1. Department of Dermatology, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea
- Publication Type:Case Report
- From:Korean Journal of Dermatology
2020;58(5):330-333
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is an adverse drug reaction that is difficult to predict. It is characterized by fever, skin rash, and internal organ involvement that usually manifests 2∼6 weeks after use of the culprit drug. The antihyperglycemic agent sitagliptin is commonly used for treating diabetes mellitus, and sitagliptin-induced DRESS syndrome has not been previously reported in Korea. Herein, we report a case of DRESS syndrome after sitagliptin use; these observations may contribute to the timely diagnosis of sitagliptin induced DRESS syndrome and help reduce associated complications or morbidities.
